Intas Pharmaceuticals in collaboration with its global Accord brand subsidiaries, has acquired UDENYCA (pegfilgrastim-cbqv) ...

Minghui Pharmaceutical ( Minghui ), a late-stage clinical biopharmaceutical company, announced the closing of a $131 million ...

Modeyso is the first and only treatment option approved by the FDA for this ultra-rare and aggressive brain tumor that affects an estimated 2,000 people in the U.S. each year, many of whom are ...

Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

Buildout includes Gerteis Macro-Pactor install to meet growing demand for complex oral solid dose development and manufacturing.

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova.

Stamoulis joins Mallinckrodt from Incyte, a leading biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. In addition ...

The Vibativ 4-Vial Starter Pak is an FDA-approved injectable antibiotic indicated to treat HABP/VABP and complicated skin and ...

Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analytical services, appointed Jarlath Keating as ...